Pramodini B Kale-Pradhan (Pramodini Kale-Pradhan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Randomized Controlled Trial

Allergic Rhinitis

Top Venues

The Annals of pharmacotherapy

Pharmacotherapy

Current drug safety

Medical reference services quarterly

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin A August, Pramodini B Kale-Pradhan
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix. Pharmacotherapy 44 (6) (2024)
Benjamin A August, Pramodini B Kale-Pradhan
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix. Pharmacotherapy (2024)
Benjamin A August, Pramodini B Kale-Pradhan
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix. Pharmacotherapy 44 (6) (2024)
Hannah Marie Ferrari, Pramodini B Kale-Pradhan, Jewel Konja, Michelle Dierker, Amber Lanae Martirosov
Systemic-Sclerosis-Related Interstitial Lung Disease: A Review of the Literature and Recommended Approach for Clinical Pharmacists. The Annals of pharmacotherapy (2023)
Benjamin A August, Pramodini B Kale-Pradhan, Christopher Alan Giuliano, Leonard Johnson
Biomarkers in the Intensive Care Setting: A Focus on using Procalcitonin and C-Reactive Protein to Optimize Antimicrobial Duration of Therapy. Pharmacotherapy (2023)
Amber Lanae Martirosov, Christopher Alan Giuliano, Macy Shupp, Sarah Channey, Pramodini B Kale-Pradhan
Zavegepant Intranasal Spray for Migraines. The Annals of pharmacotherapy (2023)
Benjamin August, Andrew Matlob, Pramodini B Kale-Pradhan
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections. The Annals of pharmacotherapy (2023)
Bianca Aprilliano, Christopher Alan Giuliano, Jason Brian Reed, Pramodini B Kale-Pradhan
Evaluation of References Supporting Hospital Pharmacy Policies. Medical reference services quarterly 42 (1) (2023)
Alison Lobkovich, Pramodini B Kale-Pradhan, Melissa Lipari
Incretin Analogs for Weight Management in Adults Without Diabetes. The Annals of pharmacotherapy (2023)
Pramodini B Kale-Pradhan, Regina Pacitto, Christopher Alan Giuliano, Leonard B Johnson
Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients. Current drug safety (2023)
Jacqueline Feist, Melissa Lipari, Pramodini B Kale-Pradhan
Tezepelumab in the Treatment of Uncontrolled Severe Asthma. The Annals of pharmacotherapy 57 (1) (2022)
Lauren Lim, Melissa Lipari, Pramodini B Kale-Pradhan
Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis. The Annals of pharmacotherapy (2022)
Helen D Berlie, Pramodini B Kale-Pradhan, Tara Orzechowski, Linda A Jaber
Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review. The Annals of pharmacotherapy 55 (11) (2021)
Melissa Lipari, Pramodini B Kale-Pradhan, Sheila M Wilhelm
Dual- Versus Mono-Bronchodilator Therapy in Moderate to Severe COPD: A Meta-analysis. The Annals of pharmacotherapy 54 (12) (2020)
Pramodini B Kale-Pradhan, Christopher Alan Giuliano, Annelise Jongekrijg, Michael Joseph Rybak
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis. Pharmacotherapy 40 (7) (2020)
Rachel Neu, Melvin A Leonard, Michelle L Dehoorne, Samantha J Scalia, Pramodini B Kale-Pradhan, Christopher Alan Giuliano
Impact of Pharmacist Involvement in Heart Failure Transition of Care. The Annals of pharmacotherapy 54 (3) (2019)
Sean M McConachie, Sheila M Wilhelm, Ashish Bhargava, Pramodini B Kale-Pradhan
Biologic-Induced Infections in Inflammatory Bowel Disease: The TNF-α Antagonists. The Annals of pharmacotherapy 52 (6) (2018)